Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Optics Express
|
September 23, 2025
Kolmogorov-Arnold network for efficient equalization in short-reach IM/DD systems
Cancan Chen, Zhaopeng Xu, Yue Liu, et al.
Oral Oncology
|
August 10, 2024
An individualized immune prognostic signature in nasopharyngeal carcinoma
Guanjie Qin, Xiaofei Liao, Bin Zhang, et al.
The Journal of Headache and Pain
|
May 20, 2025
Induction of more severe central sensitization in a medication overuse headache model mice through active ingestion of rizatriptan
Zhenjie Ma, Chenhao Li, Wenhao Bai, et al.
The Journal of Headache and Pain
|
February 6, 2026
The pPVT<sup>glu</sup>- CeA<sup>GABA</sup> circuit is involved in regulating hyperalgesia in the chronic NTG mouse model in males
Weinan Na, Huijuan Yuan, Chunxiao Yang, et al.
Plos Biology
|
November 11, 2025
The RNA-binding protein RBM39 scaffolds an m⁶A-dependent RNA decay complex that destabilizes Tat transcripts and restricts HIV-1 reactivation
Xiaohui Deng, Siyi Xie, Mo Zhou, et al.
Molecular Therapy Oncolytics
|
August 18, 2023
Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment
Baijin Xia, Keming Lin, Xuemei Wang, et al.
Journal of Translational Medicine
|
April 12, 2024
Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology
Keming Lin, Baijin Xia, Xuemei Wang, et al.
Scientific Reports
|
August 5, 2022
Identification of misdiagnosis by deep neural networks on a histopathologic review of breast cancer lymph node metastases
Cancan Chen, Shan Zheng, Lei Guo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 20, 2016
Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency
Guannan Geng, Bingfeng Liu, Cancan Chen, et al.
Plos Medicine
|
May 26, 2022
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial
Pengfei Jin, Xiling Guo, Wei Chen, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Optics Express
|
September 23, 2025
Kolmogorov-Arnold network for efficient equalization in short-reach IM/DD systems
Cancan Chen, Zhaopeng Xu, Yue Liu, et al.
Oral Oncology
|
August 10, 2024
An individualized immune prognostic signature in nasopharyngeal carcinoma
Guanjie Qin, Xiaofei Liao, Bin Zhang, et al.
The Journal of Headache and Pain
|
May 20, 2025
Induction of more severe central sensitization in a medication overuse headache model mice through active ingestion of rizatriptan
Zhenjie Ma, Chenhao Li, Wenhao Bai, et al.
The Journal of Headache and Pain
|
February 6, 2026
The pPVT<sup>glu</sup>- CeA<sup>GABA</sup> circuit is involved in regulating hyperalgesia in the chronic NTG mouse model in males
Weinan Na, Huijuan Yuan, Chunxiao Yang, et al.
Plos Biology
|
November 11, 2025
The RNA-binding protein RBM39 scaffolds an m⁶A-dependent RNA decay complex that destabilizes Tat transcripts and restricts HIV-1 reactivation
Xiaohui Deng, Siyi Xie, Mo Zhou, et al.
Molecular Therapy Oncolytics
|
August 18, 2023
Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment
Baijin Xia, Keming Lin, Xuemei Wang, et al.
Journal of Translational Medicine
|
April 12, 2024
Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology
Keming Lin, Baijin Xia, Xuemei Wang, et al.
Scientific Reports
|
August 5, 2022
Identification of misdiagnosis by deep neural networks on a histopathologic review of breast cancer lymph node metastases
Cancan Chen, Shan Zheng, Lei Guo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 20, 2016
Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency
Guannan Geng, Bingfeng Liu, Cancan Chen, et al.
Plos Medicine
|
May 26, 2022
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial
Pengfei Jin, Xiling Guo, Wei Chen, et al.
Page
of 9